The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette–Guerin
Open Access
- 1 September 2015
- journal article
- research article
- Published by Taylor & Francis in Arab Journal of Urology
- Vol. 13 (3) , 225-230
Abstract
To investigate whether the immunohistochemical expression of p53, p63 and her2/neu is correlated with the prognosis of tumour recurrence and progression in patients with non-muscle invasive (NMI) b...Keywords
This publication has 32 references indexed in Scilit:
- Immunohistochemical expression of HER2 in urothelial bladder carcinoma and its correlation with p53 and p63 expressionJournal of Microscopy and Ultrastructure, 2013
- HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladderScandinavian Journal of Urology and Nephrology, 2011
- Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladderOncology Reports, 2010
- Role of Polysomy 17 in Transitional Cell Carcinoma of the Bladder: Immunohistochemical Study of HER2/neu Expression and FISH Analysis of c-erbB-2 Gene and Chromosome 17International Journal of Surgical Pathology, 2009
- Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 UpdateJournal of Urology, 2007
- Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette–Guérin (BCG)European Urology, 2004
- P53 MUTATIONS IN BLADDER TUMORS INACTIVATE THE TRANSACTIVATION OF THE P21 AND BAX GENES, AND HAVE A PREDICTIVE VALUE FOR THE CLINICAL OUTCOME AFTER BACILLUS CALMETTE-GUERIN THERAPYJournal of Urology, 1999
- CORRELATION AND PROGNOSTIC SIGNIFICANCE OF p53, p21 WAF1/CIP1 AND Ki-67 EXPRESSION IN PATIENTS WITH SUPERFICIAL BLADDER TUMORS TREATED WITH BACILLUS CALMETTE-GUERIN INTRAVESICAL THERAPYJournal of Urology, 1999
- CORRELATION BETWEEN p53 OVER EXPRESSION AND RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY IN A HIGH RISK SELECT POPULATION OF PATIENTS WITH T1G3 BLADDER CANCERJournal of Urology, 1998
- p53 STATUS DOES NOT PREDICT INITIAL CLINICAL RESPONSE TO BACILLUS CALMETTE-GUERIN INTRAVESICAL THERAPY IN T1 BLADDER TUMORSJournal of Urology, 1998